Related Pages for AUROPHARMA

Option Chain
Max Pain
Put Call Ratio
Option Analytics
Call OI vs Put OI
Call OI Chg vs Put OI Chg
Call Vol vs Put Vol
Vega Divergence
Buildup & Unwinding
Strike Flow
Future Chain
Future Intraday Analysis
Technical
Financials
Chart
About

Search Symbol
AUROPHARMA
Aurobindo Pharma Ltd

1511.8 +0.90 (0.06%)

L: 1503.3 H: 1528
Option
- Option
- Option Chain
- Max Pain
- Put Call Ratio
- Option Analytics
Option Analysis
- Option Analysis
- Call OI vs Put OI
- Call OI Chg vs Put OI Chg
- Call Vol vs Put Vol
- Vega Divergence
- Buildup & Unwinding
- Strike Flow
Futures
- Futures
- Future Chain
- Future Intraday Analysis
Company
- Company
- Technical
- Corporate Events & News
- Financials
- Chart
- About

🎨 Holi Special Offer! Get +30 Free Days on Yearly or +10 Free Days on Quarterly — Ends 8th Mar Midnight. View Plans → 🎨 Holi Offer — Ends 8th Mar - View Plans →

NiftyInvest

Market
Max Pain
Put Call Ratio
Option

Option Chain

Straddle Option Chain

Max Pain

Max Pain Table

Put Call Ratio

Put Call Ratio Table

Option Analytics

Option Screener

Call OI vs Put OI

StrikeFlow: Call vs Put Positioning

Call OI Change vs Put OI Change

Call Vol vs Put Vol

Buildup & Unwinding

Vega Divergence

Strategy Builder

Strategy Simulator

Multi Strike OI New

Price vs OI New

Time Series New

Volatility Skew New

Near ATM OI New

Premium Decay New

OI Crossover New
Future
Company
Live News
Pricing
My View
Login
Sign-up

[--[65.84.65.76]--]

AUROPHARMA

Aurobindo Pharma Ltd

1511.8 +0.90 (0.06%)

L: 1503.3 H: 1528

0 results

No results found.

AUROPHARMA 1511.8

0.9 (0.06%)

Search symbol e.g. NIFTY, RELIANCE, CRUDEOIL

Corporate Actions
Related News

Loading corporate actions

Related News - AUROPHARMA

Aurobindo Pharma: Co subsidiary CuraTeQ Biologics receives CDSCO marketing authorisation (Form CT 23) for Bevqolva® (bevacizumab biosimilar).

16 May 2026 11:13 AM

Aurobindo Pharma: Co subsidiary CuraTeQ Biologics receives CDSCO marketing authorisation (Form CT 23) for Bevqolva® (bevacizumab biosimilar).

Aurobindo Pharma Ltd: Unit-VII Gets "Voluntary Action Indicated" Status From US FDA; 9 Observations Found.

06 May 2026 09:12 AM

Aurobindo Pharma Ltd: Unit-VII Gets "Voluntary Action Indicated" Status From US FDA; 9 Observations Found.

Aurobindo Pharma Ltd: Plans To Buy Up To 26% Of Swarnaakshu Solar Power Private Limited, Pending State Government Approval By March 31, 2026.

30 Dec 2025 11:17 AM

Aurobindo Pharma Ltd: Plans To Buy Up To 26% Of Swarnaakshu Solar Power Private Limited, Pending State Government Approval By March 31, 2026.

Empowering traders with comprehensive investment insights and advanced market analysis tools. Real-time data, intelligent analytics, and cutting-edge trading intelligence for the Indian stock markets.